BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21458456)

  • 1. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy.
    Lin KJ; Hernández-Díaz S; García Rodríguez LA
    Gastroenterology; 2011 Jul; 141(1):71-9. PubMed ID: 21458456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
    Massó González EL; García Rodríguez LA
    Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
    Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
    Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapy.
    Yasu T; Sato N; Kurokawa Y; Saito S; Shoji M
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):854-60. PubMed ID: 24040853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
    González-Pérez A; Sáez ME; Johansson S; Himmelmann A; García Rodríguez LA
    BMC Cardiovasc Disord; 2016 Aug; 16(1):164. PubMed ID: 27577589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulants.
    Youn SH; Lim H; Ju Y; Soh JS; Park JW; Kang HS; Kim SE; Moon SH; Kim JH; Park CK; Seo SI; Shin WG
    Scand J Gastroenterol; 2018 Dec; 53(12):1490-1495. PubMed ID: 30509124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan.
    Miyamoto M; Haruma K; Okamoto T; Higashi Y; Hidaka T; Manabe N
    J Gastroenterol Hepatol; 2012 Feb; 27(2):372-7. PubMed ID: 21793917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
    Schreiner GC; Laine L; Murphy SA; Cannon CP
    Crit Pathw Cardiol; 2007 Dec; 6(4):169-72. PubMed ID: 18091407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.
    de Abajo FJ; Gil MJ; Bryant V; Timoner J; Oliva B; García-Rodríguez LA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):691-701. PubMed ID: 22955795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
    Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study.
    Tsujita K; Deguchi H; Uda A; Sugano K
    J Cardiol; 2020 Jul; 76(1):51-57. PubMed ID: 32184027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.
    Kim TJ; Kim ER; Hong SN; Kim YH; Lee YC; Kim HS; Kim K; Chang DK
    Sci Rep; 2019 Aug; 9(1):11696. PubMed ID: 31406189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis.
    Song YR; Kim HJ; Kim JK; Kim SG; Kim SE
    World J Gastroenterol; 2015 Apr; 21(16):4919-24. PubMed ID: 25945005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.